Related Experiment Video
Updated: Sep 19, 2025

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
Role of circ_0012856 in modulating molecular pathways of diabetic peripheral neuropathy
Ji Chen1, Fan Zhang2, Yangyuxi Chen3
1Department of Endocrinology Hunan University of Medicine General Hospital Huaihua Hunan China.
Abstract:
Diabetic peripheral neuropathy (DPN), a common complication of diabetes mellitus, involves complex molecular pathways and the ceRNA regulatory network. Integration of diabetes-related circRNA datasets identified circ_0012856 as pivotal via least absolute shrinkage and selection operator and support vector machine recursive feature elimination algorithms. Functional enrichment analyses elucidated its involvement in DPN pathogenesis. In vitro studies showed circ_0012856 regulating EZH2 and STAT3 expressions, inhibiting autophagy, and promoting microglial M1 polarization. In vivo, experiments revealed silencing circ_0012856 alleviating DPN symptoms in diabetic mice. Overall, circ_0012856 acts as a miR-124 sponge, affecting key pathways in DPN progression and providing potential therapeutic targets.
Insights
Diabetic peripheral neuropathy (DPN) involves complex pathways. Circ_0012856 was identified as a key regulator, offering potential therapeutic targets for DPN.
Area of Science:
- Molecular biology
- Genetics
- Immunology
Background:
- Diabetic peripheral neuropathy (DPN) is a common diabetes mellitus complication.
- DPN pathogenesis involves intricate molecular pathways and the competing endogenous RNA (ceRNA) regulatory network.
Purpose of the Study:
- To identify key circular RNAs (circRNAs) involved in DPN pathogenesis.
- To elucidate the molecular mechanisms of identified circRNAs in DPN.
- To explore potential therapeutic targets for DPN.
Main Methods:
- Integration of diabetes-related circRNA datasets.
- Application of least absolute shrinkage and selection operator (LASSO) and support vector machine recursive feature elimination (SVM-RFE) algorithms.
- In vitro and in vivo experiments in cell and animal models.
Main Results:
- Circ_0012856 was identified as a pivotal circRNA in DPN.
- Circ_0012856 regulates EZH2 and STAT3 expression, inhibits autophagy, and promotes microglial M1 polarization.
- Silencing circ_0012856 alleviated DPN symptoms in diabetic mice.
- Circ_0012856 functions as a miR-124 sponge.
Conclusions:
- Circ_0012856 plays a critical role in DPN progression.
- Circ_0012856 influences key pathways, including inflammation and autophagy, in DPN.
- Circ_0012856 represents a potential therapeutic target for DPN.
More Related Videos
05:58Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
Related Concept Videos
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Insulin: The Receptor and Signaling Pathways
Circadian Rhythms and Gene Regulation
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational